(Circulation. 2005;111:1242-1249.)
© 2005 American Heart Association, Inc.
Epidemiology |
From the Department of Epidemiology (K.S.-T., S.B.), Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pa; Department of Epidemiology (R.P.W.), Tulane University School of Public Health and Tropical Medicine, New Orleans, La; Department of Psychiatry (K.A.M.), University of Pittsburgh School of Medicine, Pittsburgh, Pa; Cardiology Division (C.C., R.C.P.), Massachusetts General Hospital, and Division of Preventive Medicine, Brigham and Womens Hospital, Boston, Mass; Department of Population Health and Reproduction (B.L.L.), University of CaliforniaDavis, Davis, Calif; Feinberg School of Medicine (D.L.-J.), Northwestern University, Chicago, Ill; Department of Epidemiology (M.F.S.), School of Public Health, University of Michigan, Ann Arbor, Mich; and Department of Obstetrics, Gynecology and Womens Health (J.L.T.), New Jersey Medical School, Newark, NJ.
Correspondence to Kim Sutton-Tyrrell, Department of Epidemiology, University of Pittsburgh, 127 Parran Hall/130 DeSoto St, Pittsburgh, PA 15261. E-mail Tyrrell{}edc.pitt.edu
Received September 17, 2004; revision received December 17, 2004; accepted December 28, 2004.
Background Recent clinical trials have shifted attention away from estrogens and toward androgens and sex hormonebinding globulin (SHBG) as potential mediators of increasing cardiovascular (CV) risk in women at midlife.
Methods and Results The correlation between reproductive hormones and CV risk factors was evaluated in a multiethnic (white, black, Hispanic, Chinese, and Japanese) sample of 3297 premenopausal and perimenopausal women. Testosterone and estradiol (E2) were evaluated along with SHBG and the free androgen index (FAI), the amount of testosterone not bound by SHBG. Low SHBG and high FAI were strongly and consistently related to elevated CV risk factors (higher insulin, glucose, and hemostatic and inflammatory markers and adverse lipids) even after controlling for body mass index (P<0.001 for all). Low levels of E2 were associated with elevated CV risk factors to a lesser degree. These observations were consistent across the 5 ethnic groups. Compared with whites, blacks had higher levels of SHBG and lower levels of FAI, and Chinese had lower levels of SHBG and higher levels of FAI.
Conclusions Low SHBG and high FAI are strongly associated with CV risk factors in racially diverse women, and thus, androgens likely play a role in the CV risk profile of perimenopausal women.
Key Words: hormones aging sex menopause risk factors
This article has been cited by other articles:
|
|
T. V. Clendenen, K. L. Koenig, R. E. Shore, M. Levitz, A. A. Arslan, and A. Zeleniuch-Jacquotte Postmenopausal Levels of Endogenous Sex Hormones and Risk of Colorectal Cancer Cancer Epidemiol. Biomarkers Prev., January 1, 2009; 18(1): 275 - 281. [Abstract] [Full Text] [PDF] |
||||